Filter
4934
Filtered Results: 4934
Text search:
medicines
availability
Featured
Recommendations
468
New Publications
1357
Language
Document type
No document type
2779
Studies & Reports
924
Guidelines
631
Manuals
238
Strategic & Response Plan
193
Fact sheets
58
Training Material
57
Situation Updates
34
Resource Platforms
8
Infographics
7
Brochures
3
Online Courses
2
Countries / Regions
India
238
Global
186
Kenya
167
Ethiopia
120
South Africa
116
Uganda
111
Nepal
107
Nigeria
100
Sierra Leone
99
Malawi
99
Liberia
94
Tanzania
87
Western and Central Europe
86
Africa
86
Bangladesh
72
Zambia
71
Myanmar / Burma
69
Latin America and the Carribbean
67
Ghana
62
Rwanda
62
Ukraine
53
Syria
50
Namibia
49
Congo, Democratic Republic of
42
Philippines
42
South–East Asia Region
41
Zimbabwe
38
Senegal
31
Guinea
30
Lesotho
30
East and Southern Africa
29
Asia
29
Eastern Europe
29
Mozambique
27
Haiti
26
West and Central Africa
25
Venezuela
24
Cambodia
23
Burkina Faso
21
Botswana
21
Middle East and North Africa
21
South Sudan
20
Cameroon
17
Indonesia
17
Eastern Europe and Central Asia
16
Brazil
15
Yemen
15
Eswatini/ Swaziland
14
Russia
14
Sudan
13
Pakistan
12
Afghanistan
12
Germany
12
Lebanon
11
Benin
11
USA
10
Thailand
10
Colombia
10
Moldova
10
Jordan
9
Western Pacific Region
9
Somalia
8
North Macedonia
8
Mali
7
Côte d’Ivoire / Ivory Coast
7
Peru
7
Georgia
7
Iraq
6
Central African Republic
6
Ecuador
6
Chile
6
Laos
6
Vietnam
6
North America
6
Niger
5
Sri Lanka
5
Paraguay
5
Poland
5
Albania
5
Southern Africa
5
Tajikistan
5
Kyrgyzstan
5
Kazakhstan
5
Hungary
4
Burundi
4
Libya
4
Madagascar
4
Morocco
3
Turkey
3
Chad
3
China
3
Argentina
3
Bolivia
3
Angola
3
Mexico
3
Romania
3
Jamaica
3
Mauritius
3
Belarus
3
Togo
2
Egypt
2
Mauritania
2
Papua New Guinea
2
Serbia
2
El Salvador
2
Guatemala
2
Other region
2
Bhutan
2
Palestine
2
Canada
2
Qatar
2
Bulgaria
2
Iran
2
Gabon
2
Turkmenistan
2
Tunisia
2
United Kingdom
2
Portugal
2
Israel
2
Bosnia and Herzegovina
2
Guinea-Bissau
1
Saudi Arabia
1
Gambia
1
Malaysia
1
Dominican Republic
1
Austria
1
Switzerland
1
Cuba
1
Honduras
1
Nicaragua
1
Fiji
1
Solomon Islands
1
Italy
1
Armenia
1
Mongolia
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Estonia
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
France
1
Maldives
1
Norway
1
Spain
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1977
Clinical Guidelines
415
Public Health
306
Women & Child Health
229
Key Resources
177
Capacity Building
81
Pharmacy & Technologies
62
Annual Report MEDBOX
2
Toolboxes
HIV
420
COVID-19
356
Mental Health
355
TB
263
AMR
214
Pharmacy
136
Planetary Health
135
NCDs
135
Caregiver
131
Disability
127
Rapid Response
124
NTDs
124
Conflict
122
Ebola
115
Global Health Education
70
Refugee
61
Natural Hazards
50
Health Financing Toolbox
38
Zika
22
Specific Hazards
22
Cholera
17
Polio
11
Social Ethics
11
Typhoon
1
Health Financing
1
This guideline is intended to provide requirements to applicants wishing to submit
applications for registration of medicines in Botswana.
Objectives of the Study:
To understand the community needs, behaviors and perception for MNH in urban poor settings.
To explore various factors (both demand and supply side) affecting care seeking for MNH.
To assess the preparedness of the urban health system for providing MNH services at variou...
The global burden of disease due to mental disorders continues to rise, especially in low- and middle-income countries (LMIC). In addition to causing a large proportion of morbidity, mental disorders – especially severe mental disorders (SMD) – are linked with poorer health outcomes and increase...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities an...
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
The following is a breakdown of key considerations to guide planning and resource allocation for COVID-19 preparedness and response to support UNHCR regional and country operations in Public Health, WASH, Shelter and Settlements programmes. While some of the activities are more relevant in camps or ...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Approximately 80% of the 463 million adults worldwide with diabetes live in low-income and middle-income countries (LMICs). A major obstacle to designing evidence-based policies to improve diabetes outcomes in LMICs is the scarce availability of nat...
As we approach World Asthma Day on the May 2, 2023, we reflect on the theme “ Asthma Care for All”. Prevalence of Asthma is increasing amongst children, adolescents and adults. Under-diagnosis, underutilization of inhaled corticosteroids, inaccessibility of treatment, and unaffordability of ... are amongst the challenges that low-middle income countries are faced with. This commentary seeks to highlight the challenges, the resources available and to suggest recommendations that can be implemented to improve asthma care for all and reduce burden of asthma in Africa.
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up ...
Latent Tuberculosis Infection : Updated and consolidated guidelines for programmatic management
recommended
The consolidated guidelines are expected to provide the basis and rationale for the development of national guidelines for LTBI management, adapted to the national and local epidemiology of TB, the availability of resources, the health infrastructur...
The aim of the operational framework is to ensure 1) accurate collection, handling, shipment and storage of specimens collected in countries implementing HIV drug resistance surveillance; and 2) the availability of quality-assured HIV genotyping lab...
Countries can use this tool to collect in-depth facility inventories of biomedical equipment re-allocation, procurement and planning for COVID-19 case management. The survey assesses quantified availability and the causes for non-functioning of diff...
As a Frontline Health Care Worker or a Vaccinator, you need to counsel pregnant women about the availability, value and precautions regarding the COVID-19 vaccine. This note provides you with the information that you need to educate and support preg...
Despite recent global declines, under-five mortality remains high in many of the poorest countries. Barriers to timely
quality care, including user fees, distance to facilities and the availability of trained health workers and medical supplies,
...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing ...-related adverse effects in humans, promoting patient safety, and the rational use of medicines. The indicators proposed in this manual are based on the expected functions of pharmacovigilance centres as described in the WHO Mimimum Requirements for a Functional Pharmacovigilance System (1) (see Annex 1 of the manual).
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
hese are two parallel guidelines, one for small hospitals and another one for large hospitals. In view of heavy burden of malaria and prevalence of drug resistant falciparum malaria in the South-East Asia Region, the guidelines were developed for use by medical personnel who treat severe malaria pat...
